HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.

Abstract
Bullous pemphigoid (BP) is a common autoimmune blistering skin disorder that tends to affect the elderly. Autoantibodies (autoAbs) from BP patients react with two hemidesmosomal components: transmembrane collagen XVII (BP180 or BPAG2) and plakin family protein BP230 (BPAG1). Of these, collagen XVII (COL17) is thought to be a major autoantigen. The binding of autoAbs to COL17 following the activation of complements and inflammatory pathways eventually leads to the degradation of COL17, and this has been regarded as the main pathogenesis of BP. However, recent investigations have suggested other pathways, including a complement-independent pathway and a pathway involving IgE-autoAbs. BP-autoAbs can directly deplete COL17, leading to fragility of the dermal-epidermal junction. In addition, IgE-autoAbs to COL17 may be involved in the formation of itchy urticarial erythema associated with eosinophilic infiltration. This article summarizes the update on pathogenesis of BP, with a special focus on blister formation by autoAbs to COL17.
AuthorsWataru Nishie
JournalJournal of dermatological science (J Dermatol Sci) Vol. 73 Issue 3 Pg. 179-86 (Mar 2014) ISSN: 1873-569X [Electronic] Netherlands
PMID24434029 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2013 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Autoantibodies
  • Autoantigens
  • Non-Fibrillar Collagens
  • collagen type XVII
  • Immunoglobulin E
  • Complement System Proteins
Topics
  • Amino Acid Sequence
  • Animals
  • Autoantibodies (immunology)
  • Autoantigens (immunology, metabolism)
  • Complement System Proteins (immunology)
  • Humans
  • Immunoglobulin E (immunology)
  • Inflammation (etiology)
  • Molecular Sequence Data
  • Non-Fibrillar Collagens (immunology, metabolism)
  • Pemphigoid, Bullous (etiology, immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: